These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 232017)

  • 41. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of captopril, diuretic, and their combination in low-renin essential hypertension.
    Ferguson RK; Vlasses PH; Swanson BN
    Life Sci; 1980 Dec 22-29; 27(25-26):2519-22. PubMed ID: 7012509
    [No Abstract]   [Full Text] [Related]  

  • 43. Captopril in renovascular hypertension: long-term use in predicting surgical outcome.
    Atkinson AB; Brown JJ; Cumming AM; Fraser R; Lever AF; Leckie BJ; Morton JJ; Robertson JI
    Br Med J (Clin Res Ed); 1982 Mar; 284(6317):689-93. PubMed ID: 6802290
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
    Iimura O; Shimamoto K
    Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of captopril in the diagnosis of renal hypertension.
    McGrath BP; Matthews PG; Johnston CI
    Aust N Z J Med; 1981 Aug; 11(4):359-63. PubMed ID: 7030291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Acute antihypertensive effect of captopril in hypertensive patients: with special reference to kallikrein-kinin system].
    Mizuno K; Gotoh M; Haruyama K; Hashimoto S; Toki T; Matsui J; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1983 Oct; 59(10):1620-9. PubMed ID: 6363144
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Crossover comparison of captopril and propranolol as step 2 agents in hypertension.
    Oren A; Rotmensch HH; Vlasses PH; Riley LJ; Tadros SS; Koplin JR; Ferguson RK
    Am Heart J; 1985 Mar; 109(3 Pt 1):554-7. PubMed ID: 3883729
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism.
    Mantero F; Fallo F; Opocher G; Armanini D; Boscaro M; Scaroni C
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():289s-293s. PubMed ID: 7032817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renin- and non-renin-mediated antihypertensive actions of converting enzyme inhibitors.
    Zusman RM
    Kidney Int; 1984 Jun; 25(6):969-83. PubMed ID: 6088887
    [No Abstract]   [Full Text] [Related]  

  • 50. Efficacy of an oral angiotensin-converting enzyme inhibitor (captopril) in severe hypertension.
    Zweifler AJ; Julius S; Nicholls MG
    Arch Intern Med; 1981 Jun; 141(7):907-10. PubMed ID: 6263204
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Captopril, aldosterone and urinary kallikrein in primary hypertension.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Clin Exp Hypertens A; 1983; 5(4):523-9. PubMed ID: 6342863
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fluctuations in the plasma angiotensin I converting enzyme activity during long-term treatment with captopril.
    Staessen J; Fagard R; Lijnen P; Verschueren LJ; Amery A
    Acta Cardiol; 1982; 37(1):1-9. PubMed ID: 6282024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of captopril in essential hypertension (author's transl)].
    Mimran A; Targhetta R; Laroche B
    Nouv Presse Med; 1981 Apr; 10(19):1579-82. PubMed ID: 7025849
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of angiotensin I converting enzyme inhibitor (captopril) on blood pressure and bradykinin in patients with excessive aldosterone secretion].
    Haruyama K; Mizuno K; Yamazaki M; Toki T; Yaginuma K; Fukuchi S
    Nihon Jinzo Gakkai Shi; 1984 Apr; 26(4):437-44. PubMed ID: 6381834
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity.
    Larochelle P; Genest J; Kuchel O; Boucher R; Gutkowska Y; McKinstry D
    Can Med Assoc J; 1979 Aug; 121(3):309-16. PubMed ID: 223756
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical experience with an oral angiotensin I-converting enzyme inhibitor in hypertensive patients: effects on blood pressure and the renin-aldosterone system by a single dose (author's transl)].
    Mizuno K; Shigetomi S; Haruyama K; Matsui J; Gotho M; Fukuchi S
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):1-11. PubMed ID: 6247526
    [No Abstract]   [Full Text] [Related]  

  • 57. Long-term captopril treatment in moderate to severe hypertension.
    Santucci A; Aguglia F; De Mattia G; Ficara C; Balsano F
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):77S-79S. PubMed ID: 6753908
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Captopril withdrawal after chronic therapy.
    Vlasses PH; Koffer H; Ferguson RK; Green PJ; McElwain GE
    Clin Exp Hypertens (1978); 1981; 3(5):929-37. PubMed ID: 7026198
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hormonal responses to angiotensin blockade. Comparison between receptor antagonism and converting enzyme inhibition.
    Johnston CI; Millar JA; Casley DJ; McGrath BP; Matthews PG
    Circ Res; 1980 Jun; 46(6 Pt 2):I128-34. PubMed ID: 6247084
    [No Abstract]   [Full Text] [Related]  

  • 60. Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril.
    Waeber B; Brunner HR; Brunner DB; Curtet AL; Turini GA; Gavras H
    Hypertension; 1980; 2(2):236-42. PubMed ID: 6247269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.